(19)
(11) EP 4 568 998 A1

(12)

(43) Date of publication:
18.06.2025 Bulletin 2025/25

(21) Application number: 23853151.1

(22) Date of filing: 07.08.2023
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
G01N 33/563(2006.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07K 16/2878; C07K 2317/22; C07K 2317/569; C07K 2317/33; C07K 2317/73; C07K 2317/92; A61K 2039/505; A61K 40/11; A61K 40/31; A61K 40/4224
(86) International application number:
PCT/SG2023/050545
(87) International publication number:
WO 2024/035342 (15.02.2024 Gazette 2024/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 08.08.2022 US 202263396110 P

(71) Applicants:
  • Tikva allocell Pte. Ltd.
    Singapore 138673 (SG)
  • Agency for Science, Technology and Research
    Singapore 138632 (SG)

(72) Inventors:
  • LOW, Lionel Jianrong
    Singapore 098633 (SG)
  • TAN, Kar Wai
    Singapore 098633 (SG)
  • YEO, Siok Ping
    Singapore 098633 (SG)
  • KOH, Xinyu
    Singapore 098633 (SG)
  • KUA, Lindsay, Hsien Pin
    Singapore 098633 (SG)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) B7-H3 ANTIGEN-BINDING MOLECULES